The study focused on pathological and structural alterations of the primary visual pathway in 3–9-month-old APP/PS1 mice and their WT controls across three key stages—prior to amyloid plaque formation, at plaque onset, and during plaque enrichment. The gene discussed is PSEN1; the disease is amyloidosis.